Hyposmia caused by a head injury or a major inflammatory injury to the olfactory system may cause such a permanent impairment. Why the type of treatment is prescribed, how it will help you ...

CYR-064, Cyrano Therapeutics' lead product, is also currently being evaluated for the treatment of patients suffering from hyposmia and anosmia with various causes, including post-viral hyposmia ...

including post-viral hyposmia, is an increasingly prevalent and serious chronic sensory condition for which there is no approved drug therapy [and limited treatment options]. Hyposmia causes ...

It has been used in rehabilitative treatment for 15 years ... The study included seven consecutive patients with hyposmia or anosmia from COVID-19 lasting at least 6 months and who had a score ...

About 65 percent of people with COVID-19-induced parosmia or hyposmia regain these senses by about 18 months ... injection are being investigated as potential treatments for COVID-induced parosmia.

In fact hyposmia (decrease sense of smell ... care assessments can save lives and allow for earliest corrective treatment. Using the most effective clinically studied scents along with a scent ...

The new study, titled "A Single Arm Feasibility Study for the Treatment of Parkinson's Disease Related Hyposmia Using CYR-064 Theophylline Spray" (Protocol No. CYR-064-12), is being conducted ...